Literature DB >> 8714181

[Hemorrhagic colitis caused by verotoxigenic Escherichia coli. Presentation of 9 cases].

G Prats1, C Frías, N Margall, T Llovet, L Gaztelurrutia, R Elcuaz, A Canut, R M Bartolom-e, L Torroba, I Dorronsoro, P Coll, B Mirellis.   

Abstract

OBJECTIVE: To describe the clinical and epidemiological characteristics of nine patients with enteritis caused by verocytotoxin-producing E. coli O157. PATIENTS AND METHODS: Clinical data of patients was collected retrospectively, the isolated strains were tested for verotoxin production (VT) using Vero cell culture line, and presence of VT1 and VT2 gene sequences was detected using amplification techniques (PCR), biotype was also determined using twelve biochemical tests, and genomic macrorestriction profile (PFGE).
RESULTS: The patients' age ranged from 11 months to 70 years. The mean duration of diarrhea was 4.7 days. All patients but one had abdominal cramps, seven of nine reported hemorrhagic stools and six had fever. Three patients were affected of haematologycal neoplasia and two of them developed hemolytic-uremic syndrome as a complication. All strains produced VT2 and two of them also produced VT1. Epidemiological link between patients has not been established. Three different biotypes had been distinguished between the nine isolated strains. All but two had different macrorestriction profiles. DISCUSSION: The results obtained showed that clinical manifestations are rather inespecific, including fever (6/9 patients) and there is high association of severe complications. The heterogeneity in PFGE results obtained confirms that the cases are not related.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8714181

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  4 in total

1.  Incidence of E. coli O157:H7 and other enteropathogens in a Spanish hospital.

Authors:  A G López; J L Zazo; R D Díaz; C de Guevara
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

Review 2.  Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.

Authors:  Stephen B Freedman; Jianling Xie; Madisen S Neufeld; William L Hamilton; Lisa Hartling; Phillip I Tarr; Alberto Nettel-Aguirre; Anderson Chuck; Bonita Lee; David Johnson; Gillian Currie; James Talbot; Jason Jiang; Jim Dickinson; Jim Kellner; Judy MacDonald; Larry Svenson; Linda Chui; Marie Louie; Martin Lavoie; Mohamed Eltorki; Otto Vanderkooi; Raymond Tellier; Samina Ali; Steven Drews; Tim Graham; Xiao-Li Pang
Journal:  Clin Infect Dis       Date:  2016-02-24       Impact factor: 9.079

3.  Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: prevalence in Lugo, Spain, from 1992 through 1999.

Authors:  J E Blanco; M Blanco; M P Alonso; A Mora; G Dahbi; M A Coira; J Blanco
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

4.  Phage types and genotypes of shiga toxin-producing Escherichia coli O157:H7 isolates from humans and animals in spain: identification and characterization of two predominating phage types (PT2 and PT8).

Authors:  Azucena Mora; Miguel Blanco; Jesús E Blanco; M Pilar Alonso; Ghizlane Dhabi; Fiona Thomson-Carter; Miguel A Usera; Rosa Bartolomé; Guillermo Prats; Jorge Blanco
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.